Answer
Triumeq has no or negligible influence on driving or using machinery, but patients should be informed that dizziness has been reported with dolutegravir, and their clinical status and Triumeq’s adverse reaction profile should be considered when assessing their ability.
Sources for this answer
- Triumeq 50 mg/600 mg/300 mg film-coated tabletsViiV Healthcare UK Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 33Document updated
Sources checked